$Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)$

Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of haematology 2021-09, Vol.107 (3), p.370-373
Hauptverfasser:	Renaud, Loïc, Bossard, Jean Baptiste, Carpentier, Benjamin, Terriou, Louis, Cambier, Nathalie, Chanteau, Guillaume, Escure, Guillaume, Tilmont, Remi, Barbieux, Sarah, Wemeau, Mathieu, Hieulle, Julia, Boyle, Eileen M., Morschhauser, Franck
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenine - analogs & derivatives Adenine - therapeutic use Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Central Nervous System Neoplasms - drug therapy Central Nervous System Neoplasms - mortality Central Nervous System Neoplasms - pathology Female Humans Life Sciences Lymphoma Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - mortality Lymphoma, Large B-Cell, Diffuse - pathology Male Middle Aged Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasms, Second Primary - drug therapy Neoplasms, Second Primary - mortality Neoplasms, Second Primary - pathology Piperidines - therapeutic use Prognosis Retrospective Studies Survival Analysis Temozolomide Temozolomide - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!